SULT2B1 and ovarian cancer: Moreover, overexpression of SULT2B1 has been correlated with poor prognosis in endometrial, cervical, and ovarian cancers [23,24,25,26,27], thereby representing a potential link that merits future evaluation regarding the coexistence of adenomyosis with ovarian cancer, as implicated in the literature [28].